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Sub-Saharan Africa is hardest hit with 67% of the 
estimated 33 million HIV infected people. Ninety 
percent of the 2.0 million children infected with HIV 
in 2007 were from Sub Saharan Africa. Ninety 
percent of the children infected were as a result of 
Mother to Child Transmission (MTCT). The high 
prevalence of HIV in women of reproductive age and 
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ABSTRACT 
Objective: To ascertain the major determinants of perinatal transmission of HIV among HIV positive women 
attending ANC and delivery at the University of Maiduguri Teaching Hospital, Maiduguri.
Patients and methods: A prospective case control study of 52 HIV positive pregnant women who were 
attending ANC and delivery at university of Maiduguri Teaching Hospital (UMTH) was carried out. Known 
HIV positive mothers sent from the adult HIV clinic and those found during ANC HIV screening and 
diagnosis using rapid tests were recruited, while Fetal diagnosis of HIV was done using polymerase chain 
reaction (PCR) technique at 6 and/or at 12 weeks of birth age. Socio demographic and obstetrics history were 
obtained and analyzed using SPSS version 11 and test of significance was carried out using chi square tests.
Results: Of the 52 women that were found to be HIV positive, the perinatal transmission rate was 11.5%. 
Elective caesarean section (ELCS) was offered to 11(21.2%) and all the babies delivered through ELCS were 
2 2 
negative for HIV. Advanced maternal age (X =33.53 P <0.001), Low CD4 count (X =15.58 P =0.016), high 
2  2 
maternal viral load (X =21.85 P =0.005), prematurity (X2= 9.872 P= 0.007), low birth weight (X = 63.80 P < 
2 
0.001) and birth asphyxia(X = 24.149 P< 0.001) were the major determinants of perinatal transmission of 
HIV infection in this study. 
Conclusion: The perinatal transmission of HIV is high.  Prompt identification of both maternal and fetal risks' 
factors and Effective interventions aim at minimizing the impact of these factors before or during pregnancy 
will help to lower some of the preventable determinants of perinatal transmission.
Recommendations: A prenatal and antenatal risks reduction strategy should be advocated. All effort should 
be geared toward identifying those positive and minimized or modify risks factors through behavior change, 
prompt initiation of treatment and prophylaxis for those found positive with a view to reduce the incidence of 
perinatal transmission.
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INTRODUCTION
the high fertility rate of African women are factors 
that contribute to the comparatively high prevalence 
1
of transmission of HIV to infants . 
7
Trop J Obstet Gynaecol, 33 (1), April 2016
from the study at any point if they so wish. These 
women were followed up through delivery and the 
first 12 weeks post - partum to ascertain the status of 
their babies and possible risks factors for those found 
positive. 
This study was carried out from 12th August 2009 – 
21st February 2010 after approval was granted by the 
research and ethical committee of the hospital. 
For those that consented, an initial interview was 
conducted to obtain the socio demographic and 
Obstetrics data. The diagnosis of HIV infection was 
made in two stages i.e. the initial screening using 
@Determine Rapid tests (revised serial method), the 
rapid test detects antibodies to HIV using latex 
agglutination.  Those found positive with initial 
screening were further tested with another rapid tests 
@Stak – Pak  for diagnosis. Where these two test were 
found to be discordant a 'tie breaker (third rapid test) 
@using Unigold  was done. The rapid tests were all 
carried out in the ANC clinic within 30 minutes. 
Those found positive at the initial screening were 
confirmed with 'Western Blot' technique. This was 
done in the main immunology laboratory of the 
Hospital.  Patients who tested positive by western 
blot were offered post test counseling and enrolled in 
to the PMTCT programme to continue their ANC 
1follow up according to the national protocol , while 
negative mothers were offered post test counseling 
and appropriately counseled on how to remain 
negative. And subsequent relevant ANC follow up 
events through to delivery and first 12 weeks post 
partum in HIV positive mothers.
1According to the Nigerian national guideline 2010 , 
in addition to the normal criteria for initiation of ART 
in adults infected with HIV, pregnancy constitutes 
another indication for ART or prophylaxis. 
Treatment is offered as per the WHO clinical staging 
2and eligibility criteria.  according to the Nigerian 
PMTCT 2010 guideline irrespective of the CD4 
count all HIV positive mothers are to received 
The burden of HIV is higher in sub-Saharan Africa 
than the rest of the world because of the high level of 
heterosexual transmission, high female to male ratio, 
high total fertility rate (TFR) and high prevalence of 
2
breast feeding .
Transmission from Mother to Child of HIV is 
affected by a number of factors not all of which have 
been fully elucidated. These can be divided into viral 
(iral load, viral genotype and phenotype, viral 
resistance) maternal (maternal immunological 
status, maternal nutritional status, maternal clinical 
status, behavioural factors, antiretroviral treatment) 
Obstetrics (prolonged rupture of membranes  > 
4hours, mode of delivery, intrapartum haemorrhage, 
obstetrics procedures, invasive fetal monitoring), 
fetal (prematurity, genetic, multiple pregnancy) and 
infants factors (breast feeding, gastrointestinal 
3 - 6 
factors, immature immune system ).
The objective of this study therefore is to ascertain 
the determinants of perinatal transmission of HIV 
and recommend feasible risks reduction measures to 
minimize the perinatal transmission. 
PATIENTS AND METHODS
This was a prospective hospital based study that was 
carried out at the Department of Obstetrics and 
Gynaecology of the University of Maiduguri 
Teaching Hospital.  Booking clinics are held every 
Tuesdays. Voluntary counseling and testing (VCT) 
were offered at every booking clinic on Tuesdays and 
subsequent ANC follow up were observed on 
Wednesdays and Thursdays.  52 HIV positive 
mothers (37 cases were those found positive during 
ANC booking, while 15 were patients already of 
known HIV status referred from the adult HIV clinic 
of our centre) were recruited for the study.
Emphasis was placed on confidentiality, benefit of 
knowing their status and the fact that their 
participation will not in any way harm them or their 
babies. They were also free to opt out or withdraw 
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positive by 12 weeks of age. Observed maternal 
determinants of Perinatal transmission found in this 
study were maternal age (P <0.001), maternal CD4 (P 
=0.016) and maternal viral load at delivery (P 
=0.005) as illustrated on table I. Specifically 
maternal age group 30-39years, maternal CD4 count 
less than 350cells/mm3, and maternal viral load > 
750 cells/mm3 are important determinants in mother 
to child transmission of HIV in pregnancy as 
observed in this study.
Table II explained the relationship between maternal 
factors and fetal outcome as seen earlier.  Maternal 
CD4 less than 350 was found to influenced low birth 
weight and perinatal transmission of HIV p= 0.034 
and p= 0.016 respectively. Also maternal viral load at 
delivery was equally observed to have significant 
Influence on perinatal transmission (p = 0.005), but 
however not found to significantly affect fetal 
weight. 
Mode of delivery was found to have strong 
association with fetal age at delivery, fetal weight and 
perinatal transmission of HIV (P = 0.010, 0.015 and 
0.046 respectively).
All the babies delivered through elective caesarean 
section were observed to have reached term, of 
normal weight and HIV negative, while emergency 
c/s was offered to 1 of the mothers whose baby was 
found  to be preterm, low birth weight and HIV 
positive.
Time of maternal diagnosis of HIV infection, and 
type of intervention or treatment offered were not 
shown to statistically influence fetal out come in this 
study.
Table III illustrated the fetal factors influencing 
perinatal transmission of HIV infection. Preterm 
delivery, birth asphyxia and low birth weight were 
observed to have strong association with perinatal 
HIV infection with P= 0.007, P< 0.001 and P<0.001 
respectively 
HAART  while the infants received single dose 
nevirapine suspension 2mg/kg within 72 hours of 
birth and Zidovudine 4mg/Kg twice daily for six 
weeks. Our centre (UMTH) as one of the national 
PMTCT centre were offering HAART to all our HIV 
positive pregnant irrespective of their gestational age 
and CD4 count even before the formal released of the  
Guideline and mothers have the option to either 
breast feed or formula feed their babies whichever 
one is feasible. 
The information obtained were entered into a 
questionnaires already designed for the study. The 
infants of the HIV positive mothers were followed up 
to first 12 weeks of age to determine their HIV sero 
status using polymerase chain reaction (PCR) after 
separation amplification and reading using the PCR 
machine. This technique detects viral nucleic acid 
either RNA PCR (cell free virus in the body fluid) or 
2
DNA PCR (cell associated virus.  An infant is 
considered HIV positive if the PCR is reactive for 
viral DNA at 6 and/or 12 weeks of age. 
Data were analyzed using SPSS version 11 statistical 
package .Test of significance was done using Chi 
square test. A P value of <0.05 was accepted as 
significant.
Inclusion criteria
1. All HIV positive pregnant women that were 
st
diagnosed at booking 1  time and consented 
to participate in the study.
2. All those pregnant women of known HIV 
status that were referred from the Adult ART 
clinic that consented to participate. 
Exclusion  criteria
 1. Those that refuse to consent to participate in the 
study.
2. Those that withdrew or opted out of the 
study.  
RESULTS
Out of the 52 mothers that were found to be HIV 
positive. Six (6) of the babies were confirmed HIV 
9
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significant between the two study groups, babies 
born to HIV positive mothers were found to weigh 
less than those of HIV negative mothers with mean of 
2.87kg and 3.43kg respectively.
The high prevalence of mild birth asphyxia found in 
this study is in agreement with earlier reports in some 
10, 20, 22,parts of Nigeria. . This may be attributed to 
general reservation to avoid unnecessary intrapartum 
interventions and fetal manipulations that are 
presumed to increase the risks of perinatal 
transmission of HIV.
Several reports have confirmed the effectiveness and 
stressed the use of antiretroviral drugs in preventing 
8,14,22 -26mother to child transmission of HIV.  , in line 
with this 100% of our patients were on HAART.  The 
high perinatal transmission rate observed among the 
HIV positive mothers can be partly explained by the 
late gestational age at booking, the diagnosis of HIV 
infection was only known during the ANC hence, the 
expected timely interventions in majority of the 
mothers that could have averted fetal transmission 
were done lately.  
The role of high maternal viral load, low CD4 count, 
advanced HIV disease state, prematurity and 
obstetrics and breastfeeding practices have been 
shown to significantly increase the risk of Mother to 
27 -31child transmission of HIV . Significant maternal 
and fetal determinants of perinatal transmission 
identified in this study were high maternal viral load 
3>750cell/mL, CD4 count <350 cells/mm , delivery 
less than 37 weeks,  birth asphyxia, and low birth 
weight. Six of the  HIV positive babies were 
delivered by mothers with low CD4 count (<350 
3  cells/mm  and high viral load >500 cells/mL, while 3 
and 4 of the HIV positive babies were found to be 
premature and of low birth weight. Maternal age 30-
39 years was also found to have strong association 
with perinatal transmission of HIV infection. This is 
32in agreement with a study from Congo Brazzaville.   
DISCUSSION 
The HIV Seroprevalence rate found among the study 
population is 10.4%, which is similar to 11.8% and 
7
10.5% reported from the same institution in 2003  
8
and 2004  respectively, while the perinatal 
transmission rate is 11.5%. Our findings though 
within the range of 1.2% - 12% reported in most 
2
states of Nigeria , is however higher than the national 
2.
Seroprevalence rate of 4.4% reported in 2005  Other 
Hospital based studies from Nigeria have equally 
9, 10
reported much lower prevalence rates  compared to 
our finding.  The higher prevalence rate from our 
studies might have been influence by the fact that the 
study centre is a HIV designated treatment centre and 
some of our ANC clients were enrolled into the 
PMTCT programmed from the adult clinic.
Elective caesarean section though not a popular 
method of preventing perinatal transmission of HIV 
11
in developing countries , was offered to 21.2% of 
12
our patients, this is similar to reported in Makurdi  
(21.7%), but much higher than 10.3%  reported from 
9
Kano , Nigeria. The justification for the high elective 
caesarean section rate in this study was informed by 
the recommendation that this option of delivery 
should be offered to HIV positive mothers in our 
environment to prevent mother to child transmission 
13
of HIV . All the babies delivered through elective 
caesarean section were found to be HIV negative, 
hence the choice of this mode of delivery by their 
mothers was a wise decision aim at preventing 
transmission of HIV to their neonates. A much larger 
trial have also advocated elective caesarean section 
as an effective way to minimize perinatal 
transmission of HIV particularly for those on 
prophylaxis and those on HAART with detectable 
14,15
viral load.     
Several studies have previously established that 
HIV-1 infection in pregnancy is associated with 
10,16 -21.    
prematurity and low birth weight. Though the 
difference in birth weight was not statistically 
10
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All the mothers in the study group choose to formula 
feed their babies; this is surprising because 
breastfeeding has a very strong cultural tie 
particularly in this environment. Effective 
counseling, the relatively high level of education of 
the HIV positive mothers, and about 30% of them 
were enrolled in to the PMTCT programme from the 
adult ART clinic might have been responsible for the 
increase uptake of breast milk substitute as an 
alternative mode of feeding. The advantage of 
formula feeding over breast milk for the prevention 
of postnatal transmission of HIV had been reported 
8, 33 -35
by many researchers.    
CONCLUSION
The perinatal transmission of HIV is high.  Prompt 
identification of both maternal and fetal risks' factors 
and Effective interventions aim at minimizing the 
impact of these factors before or during pregnancy 
will help to lower some of the preventable 
determinants of perinatal transmission.
RECOMMENDATIONS
A prenatal and antenatal risks reduction strategy 
should be advocated. All effort should be geared 
toward identifying those positive and minimized or 
modify risks factors through behavior change, 
prompt initiation of treatment and prophylaxis for 
those found positive with a view to reduce the 
incidence of perinatal transmission.
Table I: Maternal determinants of perinatal 
transmission of HIV *(N=51) = live birth
Age      HIV negative babies     HIV positive babies     Total 
<20                    0                           1                                   1              
20-24                10                          0                                  10
25-29                19                          1                                  20
30-34                 9                           2                                  1
35-39                 6                           2                                   8        
=40                    1                           0                                   1
Total                45                          6                  
                
*51




Primigravida     3                            1                                 4
2-4                    25                           1                               26
5-7                    16                           4                               20 
=8                      1                            0                                 1
Total                45                           6                            
    
*51
X2 =4.64     P =0.590
                  
Education 
 
Nil                     7                              2                               9
Primary             11                            1                       
      
12
Secondary         17                            1                             18
Post-secondary    6                           0                              6
 
Tertiary              4                             2                              6
 
Total                 45                            6                           * 51




<250                   5                           4                               10         
250-349             21                          2                               23
350-499             13                          0                               13
=500                   6                           0                          
       
6
Total                 45                           6                              *51






Undetected        10                          0                       
       
10
 
201-500              16                          0                              16
501-750              12                          2                              14 
751-1000             7                           2                             9
>1000                  0                           2                                2
Total                  45                           6                             *51
X2 =21.85     P =0.005
11
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